# Paraneoplastic Cushing Syndrome Unmasking Small Cell Lung Cancer: A Rare Presentation

**Authors:** Jawad Malik, Laraib Arshad

PMC · DOI: 10.7759/cureus.88382 · 2025-07-20

## TL;DR

A rare case of small cell lung cancer was diagnosed through symptoms of paraneoplastic Cushing syndrome, highlighting the need for multidisciplinary care.

## Contribution

This case report adds to the understanding of atypical cancer presentations through paraneoplastic syndromes.

## Key findings

- A lung mass was identified as small cell lung cancer through bronchoscopy biopsy.
- Paraneoplastic Cushing syndrome was confirmed by elevated cortisol and ACTH levels.
- Multidisciplinary care was essential for managing the patient's metabolic and cancer-related conditions.

## Abstract

We present a case of a middle-aged woman who presented with chest pain and shortness of breath. Laboratory tests revealed persistent hypokalaemia, hyperglycaemia, and metabolic alkalosis despite treatment. Imaging identified a mass near the right hilum suggestive of lung malignancy. Endocrine evaluation showed markedly elevated cortisol and adrenocorticotropic hormone levels, consistent with paraneoplastic Cushing syndrome caused by ectopic hormone production. The analysis of the lung biopsy obtained through bronchoscopy confirmed the diagnosis of small cell lung cancer (SCLC). The patient was treated with metyrapone and spironolactone to stabilise her metabolic abnormalities and was subsequently referred for chemotherapy following a multidisciplinary team review. This case highlights the importance of recognising paraneoplastic syndromes as atypical presentations of malignancy and emphasises the role of a coordinated, multidisciplinary approach in diagnosis and management.

## Linked entities

- **Chemicals:** metyrapone (PubChem CID 4174), spironolactone (PubChem CID 5833)
- **Diseases:** Cushing syndrome (MONDO:0018912), small cell lung cancer (MONDO:0008433)

## Full-text entities

- **Diseases:** chest pain (MESH:D002637), shortness of breath (MESH:D004417), metabolic abnormalities (MESH:D008659), paraneoplastic syndromes (MESH:D010257), Paraneoplastic Cushing Syndrome (MESH:D003480), malignancy (MESH:D009369), lung malignancy (MESH:D008175), metabolic alkalosis (MESH:D000471), SCLC (MESH:D055752)
- **Chemicals:** cortisol (MESH:D006854), spironolactone (MESH:D013148), metyrapone (MESH:D008797)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12277093/full.md

---
Source: https://tomesphere.com/paper/PMC12277093